Source: BioPortfolio

T.A. Sciences: First Randomized DoubleBlind PlaceboControlled Study to Show Telomeres Getting Longer in Humans

This new study utilizing T.A. Sciences TA65MD&174; shows compelling scientific evidence in its ability to activate telomerase and lengthen telomeres.New York NY PRWEB June 07 2016 A new study conducted on 97 relatively healthy cytomegaloviruspositive ...

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
100-250
Noel Thomas Patton's photo - Founder & CEO of T.A. Sciences

Founder & CEO

Noel Thomas Patton

CEO Approval Rating

70/100